The role of the systemic inflammatory response in predicting outcomes in patients with advanced inoperable cancer: Systematic review and meta -analysis
Top Cited Papers
Open Access
- 9 June 2017
- journal article
- review article
- Published by Elsevier BV in Critical Reviews in Oncology/Hematology
- Vol. 116, 134-146
- https://doi.org/10.1016/j.critrevonc.2017.06.002
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- The systemic inflammation-based neutrophil–lymphocyte ratio: Experience in patients with cancerCritical Reviews in Oncology/Hematology, 2013
- Cancer and systemic inflammation: stage the tumour and stage the hostBritish Journal of Cancer, 2013
- Development of Ipilimumab: Contribution to a New Paradigm for Cancer ImmunotherapySeminars in Oncology, 2010
- Inflammatory cytokines are associated with the development of symptom burden in patients with NSCLC undergoing concurrent chemoradiation therapyBrain, Behavior, and Immunity, 2010
- An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancerProceedings of the Nutrition Society, 2008
- C-Reactive Protein and All-Cause Mortality in a Large Hospital-Based CohortClinical Chemistry, 2008
- Adipokines and ghrelin in gastric cancer cachexiaWorld Journal of Gastroenterology, 2008
- The presence of a systemic inflammatory response predicts poorer survival in patients receiving adjuvant 5-FU chemotherapy following potentially curative resection for colorectal cancerBritish Journal of Cancer, 2006
- A Cytokine-Based Neuroimmunologic Mechanism of Cancer-Related SymptomsNeuroimmunomodulation, 2004
- Normal values for peripheral blood white cell counts in women of four different ethnic origins.Journal of Clinical Pathology, 1984